Altamira Therapeutics Ltd.
CYTOFOTCHealthcare · Pharmaceutical Preparations · D0 · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annualNo structured XBRL financials available (common for pre-2009 filers, foreign issuers, or companies that never reported as a US public company).
Signs
● 1 severe● 0 good- Filed a late-filing notice (Form NT) — missed an SEC deadline
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Risk flags
late SEC filings- NT 20-Fmissed a reporting deadline ↗May 1, 2023
A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.
Short interest
FINRA · bi-monthly| Settlement | Shares short | Days to cover | Δ vs prior |
|---|---|---|---|
| May 15, 2026 | 16,859 | 1.5 | -0.1% |
| Apr 30, 2026 | 16,881 | 4.1 | +0.1% |
| Apr 15, 2026 | 16,859 | 16.7 | 0.0% |
| Mar 31, 2026 | 16,859 | 4.1 | 0.0% |
| Mar 13, 2026 | 16,859 | 1.1 | 0.0% |
Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.
Recent SEC filings
All filings ↗- 15-12GFORM 15-12BFeb 27, 2026
- 6-KREPORT OF FOREIGN PRIVATE ISSUERAug 29, 2025
- 25-NSEJun 17, 2025
- 6-KFORM 6-KJun 11, 2025
- SCHEDULE 13G/AMay 15, 2025
- 6-KREPORT OF FOREIGN PRIVATE ISSUERMay 9, 2025
- SCHEDULE 13D/AMay 6, 2025
- 20-FANNUAL REPORTApr 30, 2025
- 6-KREPORT OF FOREIGN PRIVATE ISSUERApr 30, 2025
- S-8REGISTRATION STATEMENTApr 4, 2025
- 6-KREPORT OF FOREIGN PRIVATE ISSUERMar 10, 2025
- SCHEDULE 13G/AFeb 14, 2025
- 6-KREPORT OF FOREIGN PRIVATE ISSUERDec 20, 2024
- SC 13GNov 14, 2024
- 6-KREPORT OF FOREIGN PRIVATE ISSUEROct 4, 2024
Event-driven situations (1)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.